- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Wilson disease
- Meeting Date: November 2021
- Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 1265KB)
- Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 143KB)
Trientine – November 2021
Trientine: Tablet 150 mg (as tetrahydrochloride); Cuprior®
Last updated
18 March 2022